These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21927860)

  • 1. Acute stent thrombosis during percutaneous coronary intervention. Treatment with tirofiban.
    Canpolat U; Sunman H; Yorgun H; Atalar E
    Herz; 2012 May; 37(3):333-5. PubMed ID: 21927860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of late sirolimus-eluting stent thrombosis after tirofiban treatment.
    Karakurt O; Cagirci G; Kilic H; Akdemir R
    Heart Vessels; 2009 Sep; 24(5):388-90. PubMed ID: 19784825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of acute stent thrombosis treated successfully with intracoronary tirofiban.
    Erden I; Ozhan H; Ordu S
    Kardiol Pol; 2010 Apr; 68(4):485-7; discussion 488. PubMed ID: 20425719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a high bolus dose of tirofiban with half-dose thrombolytics for the treatment of subacute stent thrombosis.
    Di Pasquale P; Cannizzaro S; Paterna S
    Acta Cardiol; 2005 Feb; 60(1):61-3. PubMed ID: 15779855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial perfusion imaging of subacute stent thrombosis after percutaneous coronary intervention.
    Tsai YC; Yen RF; Shiau YC; Liao PC
    Clin Nucl Med; 2008 Jun; 33(6):414-5. PubMed ID: 18496450
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
    Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
    Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of a huge spontaneous coronary artery thrombus with a new antiplatelet agent and coronary angioplasty.
    Akdemir R; Uyan C
    Int J Cardiol; 2003 May; 89(1):87-9. PubMed ID: 12727009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intracoronary thrombus using tirofiban in a patient with normal coronary arteries.
    Ozeren A; Aydin M; Ozkökeli M; Unalacak M; Bilge M
    Jpn Heart J; 2004 Mar; 45(2):343-6. PubMed ID: 15090712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty.
    Uyarel H; Uzunlar B; Unal Dayi S; Tartan Z; Samur H; Kasikcioglu H; Akgul O; Simsek D; Erdem I; Okmen E; Cam N
    Cardiology; 2006; 105(3):168-75. PubMed ID: 16479104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of thrombus aspiration combined with tirofiban in patients with acute myocardial infarction with elective percutaneous coronary intervention.
    Liu X; Dong P; Xing S; Wang H; Li Z; Zhang H; Yang X; Wang S; Zhai Q
    J Int Med Res; 2013 Oct; 41(5):1532-40. PubMed ID: 23963850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subacute intracoronary stent thrombosis in a patient with polycythaemia vera].
    Hvelplund A; Hansen PR
    Ugeskr Laeger; 2006 Nov; 168(47):4104-5. PubMed ID: 17134610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspiration thrombectomy and intracoronary tirofiban via GuideLiner
    Fry J; Naqvi A; Bahia A; Seto A
    Future Cardiol; 2017 Mar; 13(2):131-135. PubMed ID: 28169555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
    JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent undersizing can result in procedure-related very late stent thrombosis.
    Ramcharitar S; Ligthart J; Van der Giessen WJ
    J Invasive Cardiol; 2007 Sep; 19(9):E276-7. PubMed ID: 17827520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.
    Zhao XQ; Théroux P; Snapinn SM; Sax FL
    Circulation; 1999 Oct; 100(15):1609-15. PubMed ID: 10517731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term tirofiban infusion before percutaneous coronary intervention in patients with angiographically massive intracoronary thrombus.
    Timurkaynak T; Arslan U; Balcioglu S; Turkoglu S
    Saudi Med J; 2008 Jan; 29(1):42-7. PubMed ID: 18176667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.
    Assali AR; Sdringola S; Ghani M; Westbrook LA; Anderson HV; Schroth G; Fujise K; Smalling RW; Rosales OR
    J Invasive Cardiol; 2000 Sep; 12(9):460-3. PubMed ID: 10973371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stent thrombosis in patients with myocardial infarction].
    Rogan SV; Arablinskiĭ AV; Solov'ev OP
    Kardiologiia; 2003; 43(2):77-81. PubMed ID: 12891277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.